Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2017

Open Access 01-12-2017 | Research

Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California

Authors: Barrot H. Lambdin, Alex H. Kral, Megan Comfort, Andrea M. Lopez, Jennifer Lorvick

Published in: Addiction Science & Clinical Practice | Issue 1/2017

Login to get access

Abstract

Background

People who smoke crack cocaine and people who inject drugs are at-risk for criminal justice involvement as well as HIV and HCV infection. Compared to criminal justice involvement, substance use treatment (SUT) can be cost-effective in reducing drug use and its associated health and social costs. We conducted a cross-sectional study of people who smoke crack cocaine and people who inject drugs to examine the association between incarceration, community supervision and substance use treatment with HIV/HCV testing, components of the HIV treatment cascade, social and physical vulnerability and risk behavior.

Methods

Targeted sampling methods were used to recruit people who smoke crack cocaine and people who inject drugs (N = 2072) in Oakland, California from 2011 to 2013. Poisson regression models were used to estimate adjusted prevalence ratios between study exposures and outcomes.

Results

The overall HIV prevalence was 3.3% (95% CI 2.6–4.1). People previously experiencing incarceration were 21% (p < 0.001) and 32% (p = 0.001), respectively, more likely to report HIV and HCV testing; and were not more likely to report receiving HIV care or initiating ART. People previously experiencing community supervision were 17% (p = 0.001) and 15% (p = 0.009), respectively, more likely to report HIV and HCV testing; and were not more likely to report receiving HIV care or initiating ART. People with a history of SUT were 15% (p < 0.001) and 23% (p < 0.001), respectively, more likely to report receiving HIV and HCV testing, 67% (p = 0.016) more likely to report HIV care, and 92% (p = 0.012) more likely to report HIV treatment initiation. People previously experiencing incarceration or community supervision were also more likely to report homelessness, trouble meeting basic needs and risk behavior.

Conclusions

People with a history of substance use treatment reported higher levels of HCV and HIV testing and greater access to HIV care and treatment among HIV-positive individuals. People with a history of incarceration or community supervision reported higher levels of HCV and HIV testing, but not greater access to HIV care or treatment among HIV-positive individuals., Substance use treatment programs that are integrated with other services for HIV and HCV will be critical to simultaneously address the underlying reasons drug-involved people engage in drug-related offenses and improve access to essential medical services.
Literature
2.
go back to reference Bonczar TP. Prevalence of imprisonment in the U.S. population, 1974–2001. Washington: Bureau of Justice Statistics, US Department of Justice; 2003. Bonczar TP. Prevalence of imprisonment in the U.S. population, 1974–2001. Washington: Bureau of Justice Statistics, US Department of Justice; 2003.
3.
go back to reference Glaze LE, Danielle K. Correctional populations in the United States, 2013. Washington: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2014. Glaze LE, Danielle K. Correctional populations in the United States, 2013. Washington: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2014.
4.
go back to reference Wagner P, Sakala L, Begley J. States of incarceration: the global context. 2015. Accessed 10 June 2015. Wagner P, Sakala L, Begley J. States of incarceration: the global context. 2015. Accessed 10 June 2015.
5.
go back to reference Bonczar T, Herberman E. Probation and parole in the United States, 2013. 2013. Accessed 10 June 2015. Bonczar T, Herberman E. Probation and parole in the United States, 2013. 2013. Accessed 10 June 2015.
6.
go back to reference University TNCoAaSAaC. Behind bars II: substance abuse and America’s prison population. 2010. Accessed 6 June 2015. University TNCoAaSAaC. Behind bars II: substance abuse and America’s prison population. 2010. Accessed 6 June 2015.
7.
go back to reference CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas. HIV surveillance report, vol 8, no 5 2011. Accessed 10 June 2015. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas. HIV surveillance report, vol 8, no 5 2011. Accessed 10 June 2015.
8.
go back to reference Wenbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR. 2003;52(RR01):1–33. Wenbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR. 2003;52(RR01):1–33.
9.
go back to reference CDC. HIV in correctional settings. 2014. Accessed 10 June 2015. CDC. HIV in correctional settings. 2014. Accessed 10 June 2015.
10.
go back to reference Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–26.CrossRefPubMedPubMedCentral Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–26.CrossRefPubMedPubMedCentral
11.
go back to reference Sterne J, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352–63.CrossRefPubMed Sterne J, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352–63.CrossRefPubMed
12.
13.
go back to reference Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral
14.
15.
go back to reference Ogbuagu O, Bruce RD. Reaching the unreached: treatment as prevention as a workable strategy to mitigate HIV and its consequences in high-risk groups. Curr HIV/AIDS Rep. 2014;11(4):505–12.CrossRefPubMed Ogbuagu O, Bruce RD. Reaching the unreached: treatment as prevention as a workable strategy to mitigate HIV and its consequences in high-risk groups. Curr HIV/AIDS Rep. 2014;11(4):505–12.CrossRefPubMed
16.
go back to reference Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann Intern Med. 1993;118(2):139–45.CrossRefPubMed Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann Intern Med. 1993;118(2):139–45.CrossRefPubMed
17.
go back to reference Baillargeon J, Giordano TP, Harzke AJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010;24(6):389–94.CrossRefPubMedPubMedCentral Baillargeon J, Giordano TP, Harzke AJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010;24(6):389–94.CrossRefPubMedPubMedCentral
18.
go back to reference Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr. 2010;55(Suppl 1):S49–55.CrossRefPubMedPubMedCentral Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr. 2010;55(Suppl 1):S49–55.CrossRefPubMedPubMedCentral
19.
go back to reference Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med. 2003;138(3):187–90.CrossRefPubMed Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med. 2003;138(3):187–90.CrossRefPubMed
20.
go back to reference Strock P, Mossong J, Hawotte K, Arendt V. Access to treatment of hepatitis C in prison inmates. Dig Dis Sci. 2009;54(6):1325–30.CrossRefPubMed Strock P, Mossong J, Hawotte K, Arendt V. Access to treatment of hepatitis C in prison inmates. Dig Dis Sci. 2009;54(6):1325–30.CrossRefPubMed
21.
go back to reference Basu S, Smith-Rohrberg D, Hanck S, Altice FL. HIV testing in correctional institutions: evaluating existing strategies, setting new standards. AIDS Public Policy J. 2005;20(1–2):3–24.PubMed Basu S, Smith-Rohrberg D, Hanck S, Altice FL. HIV testing in correctional institutions: evaluating existing strategies, setting new standards. AIDS Public Policy J. 2005;20(1–2):3–24.PubMed
23.
go back to reference Haley DF, Golin CE, Farel CE, et al. Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners’ perspectives before and after community reentry. BMC Public Health. 2014;14:1253.CrossRefPubMedPubMedCentral Haley DF, Golin CE, Farel CE, et al. Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners’ perspectives before and after community reentry. BMC Public Health. 2014;14:1253.CrossRefPubMedPubMedCentral
24.
go back to reference Pope LG, Smith TE, Wisdom JP, Easter A, Pollock M. Transitioning between systems of care: missed opportunities for engaging adults with serious mental illness and criminal justice involvement. Behav Sci Law. 2013;31(4):444–56.CrossRefPubMed Pope LG, Smith TE, Wisdom JP, Easter A, Pollock M. Transitioning between systems of care: missed opportunities for engaging adults with serious mental illness and criminal justice involvement. Behav Sci Law. 2013;31(4):444–56.CrossRefPubMed
26.
go back to reference Belenko S, Langley S, Crimmins S, Chaple M. HIV risk behaviors, knowledge, and prevention education among offenders under community supervision: a hidden risk group. AIDS Educ Prev. 2004;16(4):367–85.CrossRefPubMed Belenko S, Langley S, Crimmins S, Chaple M. HIV risk behaviors, knowledge, and prevention education among offenders under community supervision: a hidden risk group. AIDS Educ Prev. 2004;16(4):367–85.CrossRefPubMed
27.
go back to reference Gordon MS, Kinlock TW, McKenzie M, Wilson ME, Rich JD. Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial. AIDS Behav. 2013;17(6):2022–30.CrossRefPubMedPubMedCentral Gordon MS, Kinlock TW, McKenzie M, Wilson ME, Rich JD. Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial. AIDS Behav. 2013;17(6):2022–30.CrossRefPubMedPubMedCentral
28.
go back to reference McVay D, Schiraldi V, Ziedenberg J. Treatment or incarceration? National and state findings on the efficacy and cost savings of drug treatment versus imprisonment. 2014. Accessed 10 June 2015. McVay D, Schiraldi V, Ziedenberg J. Treatment or incarceration? National and state findings on the efficacy and cost savings of drug treatment versus imprisonment. 2014. Accessed 10 June 2015.
29.
go back to reference Zarkin GA, Cowell AJ, Hicks KA, et al. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012;21(6):633–52.CrossRefPubMed Zarkin GA, Cowell AJ, Hicks KA, et al. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012;21(6):633–52.CrossRefPubMed
30.
go back to reference Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84(2):188–94.CrossRefPubMed Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84(2):188–94.CrossRefPubMed
31.
go back to reference Reddon H, Milloy MJ, Simo A, Montaner J, Wood E, Kerr T. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS Behav. 2014;18(4):740–6.CrossRefPubMedPubMedCentral Reddon H, Milloy MJ, Simo A, Montaner J, Wood E, Kerr T. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS Behav. 2014;18(4):740–6.CrossRefPubMedPubMedCentral
32.
go back to reference Roux P, Carrieri MP, Villes V, et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction. 2008;103(11):1828–36.CrossRefPubMed Roux P, Carrieri MP, Villes V, et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction. 2008;103(11):1828–36.CrossRefPubMed
33.
go back to reference Uhlmann S, Milloy MJ, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907–13.CrossRefPubMedPubMedCentral Uhlmann S, Milloy MJ, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907–13.CrossRefPubMedPubMedCentral
38.
go back to reference Council US. Alameda County probationer as of July 2010 and Parolee as of Oct 2010. 2010. Accessed 24 Aug 2015. Council US. Alameda County probationer as of July 2010 and Parolee as of Oct 2010. 2010. Accessed 24 Aug 2015.
39.
go back to reference Department ACPH. How place, racism and poverty matter for health in Alameda County. 2013. Accessed 15 May 2015. Department ACPH. How place, racism and poverty matter for health in Alameda County. 2013. Accessed 15 May 2015.
40.
go back to reference Kral AH, Malekinejad M, Vaudrey J, et al. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health. 2010;87(5):839–50.CrossRefPubMedPubMedCentral Kral AH, Malekinejad M, Vaudrey J, et al. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. J Urban Health. 2010;87(5):839–50.CrossRefPubMedPubMedCentral
41.
go back to reference Watters J, Biernack P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;36:416–30.CrossRef Watters J, Biernack P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;36:416–30.CrossRef
42.
go back to reference Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed
43.
go back to reference Comfort M, Lopez A, Powers C, Kral AH, Lorvick J. How institutions deprive: ethnography, social work, and interventionist ethics among the hypermarginalized. Russell Sage J Soc Sci. 2015;1(1):100–19. Comfort M, Lopez A, Powers C, Kral AH, Lorvick J. How institutions deprive: ethnography, social work, and interventionist ethics among the hypermarginalized. Russell Sage J Soc Sci. 2015;1(1):100–19.
44.
go back to reference Gelberg L, Gallagher T, Andersen R, Koegel P. Competing priorities as a barrier to medical care among homeless adults in Los Angeles. Am J Public Health. 1997;87(2):217–20.CrossRefPubMedPubMedCentral Gelberg L, Gallagher T, Andersen R, Koegel P. Competing priorities as a barrier to medical care among homeless adults in Los Angeles. Am J Public Health. 1997;87(2):217–20.CrossRefPubMedPubMedCentral
45.
go back to reference Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1(4):383–92. Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1(4):383–92.
46.
go back to reference Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91(11):1842–6.CrossRefPubMedPubMedCentral Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91(11):1842–6.CrossRefPubMedPubMedCentral
47.
go back to reference Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health. 2001;91(1):46–7.CrossRefPubMedPubMedCentral Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health. 2001;91(1):46–7.CrossRefPubMedPubMedCentral
48.
go back to reference Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.CrossRefPubMed Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397–401.CrossRefPubMed
49.
go back to reference Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987–1998. Am J Epidemiol. 2003;157(10):915–22.CrossRefPubMed Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987–1998. Am J Epidemiol. 2003;157(10):915–22.CrossRefPubMed
50.
go back to reference Stata Statistical Software. Release 14 [computer program]. College Station: StataCorp LP; 2015. Stata Statistical Software. Release 14 [computer program]. College Station: StataCorp LP; 2015.
52.
go back to reference Pathela P. Incarceration: a prime opportunity for sexually transmitted infection control. Sex Transm Dis. 2014;41(3):166–7.CrossRefPubMed Pathela P. Incarceration: a prime opportunity for sexually transmitted infection control. Sex Transm Dis. 2014;41(3):166–7.CrossRefPubMed
53.
go back to reference Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.CrossRefPubMedPubMedCentral Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.CrossRefPubMedPubMedCentral
54.
go back to reference Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5–16.CrossRefPubMedPubMedCentral Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5–16.CrossRefPubMedPubMedCentral
55.
go back to reference Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD. Incarceration, community health, and racial disparities. J Health Care Poor Underserved. 2013;24(1):78–88.CrossRefPubMed Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD. Incarceration, community health, and racial disparities. J Health Care Poor Underserved. 2013;24(1):78–88.CrossRefPubMed
56.
go back to reference Lorvick J, Comfort M, Krebs CP, Kral AH. Health service use and social vulnerability in a community-based sample of women on probation and parole, 2011-2013. Health Justice. 2015;3(13):1–6. Lorvick J, Comfort M, Krebs CP, Kral AH. Health service use and social vulnerability in a community-based sample of women on probation and parole, 2011-2013. Health Justice. 2015;3(13):1–6.
57.
go back to reference Drucker E. A plague of prisons: the epidemiology of mass incarceration in America. New York: The New Press; 2011. Drucker E. A plague of prisons: the epidemiology of mass incarceration in America. New York: The New Press; 2011.
58.
go back to reference Pager D, Western B, Sugie N. Sequencing disadvantage: barriers to employment facing young black and white men with criminal records. Ann Am Acad Polit Soc Sci. 2009;623:195–213.CrossRef Pager D, Western B, Sugie N. Sequencing disadvantage: barriers to employment facing young black and white men with criminal records. Ann Am Acad Polit Soc Sci. 2009;623:195–213.CrossRef
59.
go back to reference Mallik-Kane K, Cisher C. Health and priosner reentry: how physical, mental and substance abuse conditions shape the process of reintegration. Washington: Urban Institute; 2008. Mallik-Kane K, Cisher C. Health and priosner reentry: how physical, mental and substance abuse conditions shape the process of reintegration. Washington: Urban Institute; 2008.
60.
go back to reference Khan MR, Golin CE, Friedman SR, et al. STI/hiv sexual risk behavior and prevalent STI among incarcerated African American men in committed partnerships: the significance of poverty, mood disorders, and substance use. AIDS Behav. 2015;19(8):1478–90.CrossRefPubMedPubMedCentral Khan MR, Golin CE, Friedman SR, et al. STI/hiv sexual risk behavior and prevalent STI among incarcerated African American men in committed partnerships: the significance of poverty, mood disorders, and substance use. AIDS Behav. 2015;19(8):1478–90.CrossRefPubMedPubMedCentral
61.
go back to reference Perlis TE, Des Jarlais DC, Friedman SR, Arasteh K, Turner CF. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction. 2004;99(7):885–96.CrossRefPubMed Perlis TE, Des Jarlais DC, Friedman SR, Arasteh K, Turner CF. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction. 2004;99(7):885–96.CrossRefPubMed
62.
go back to reference Koepsell TD, Weiss NS. Epidemiologic methods: studying the occurence of illness. New York: Oxford University Press; 2003. Koepsell TD, Weiss NS. Epidemiologic methods: studying the occurence of illness. New York: Oxford University Press; 2003.
63.
go back to reference Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253–63.CrossRefPubMed Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253–63.CrossRefPubMed
Metadata
Title
Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California
Authors
Barrot H. Lambdin
Alex H. Kral
Megan Comfort
Andrea M. Lopez
Jennifer Lorvick
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2017
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-017-0078-9

Other articles of this Issue 1/2017

Addiction Science & Clinical Practice 1/2017 Go to the issue